UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between blood cancer (leukaemia) and melanoma clinical trials and research opportunities
Leukaemia, lymphoma, and myeloma collectively represent a significant trial landscape. CAR-T cell therapy is a major focus across blood cancers.
Melanoma has been transformed by checkpoint immunotherapy and BRAF/MEK targeted therapy. It remains one of the most active immunotherapy trial areas.
Blood cancer trials include cellular therapies (CAR-T) and transplant approaches. Melanoma trials pioneered checkpoint inhibitors now used across cancers.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
